← Back to patent-cliff list
Paracetamol
Tier C — Watch / tradeParacetamol
Neumentum Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PTGFR, COX-2
Indications (approved)：Postoperative pain, Headache, Patent ductus arteriosus, Pain, Kidney disease, 急性疼痛, 急性流感, Influenza virus infection
Regional status
US
-
EU
Phase III
2026-09-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Paracetamol?
Approved indications include: Postoperative pain, Headache, Patent ductus arteriosus, Pain, Kidney disease, 急性疼痛, 急性流感, Influenza virus infection.
When does the Paracetamol patent expire?
No public expiry year is available for Paracetamol yet; this page updates once verified.
How do I get a quote for Paracetamol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06